Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 08-May-18 4:24 PM View:  | Chao Allen Director | Impax Laboratories, LLC (IPXL) | 04-May-18 | Disposition | 5,408 | -- | -- | (100%) 5.41K to 0 | |
| 08-May-18 4:20 PM View: | Benet Leslie Z Director | Impax Laboratories, LLC (IPXL) | 04-May-18 | Disposition | 4,742 | -- | -- | (100%) 4.74K to 0 | |
| 08-May-18 4:14 PM View: | Nestor Michael President, Impax Specialty | Impax Laboratories, LLC (IPXL) | 04-May-18 | Disposition | 76,524 | -- | -- | (100%) 76.52K to 0 | |
| 08-May-18 4:19 PM View: | Burr Robert L Director | Impax Laboratories, LLC (IPXL) | 04-May-18 | Disposition | 5,408 | -- | -- | (100%) 5.41K to 0 | |
| 08-May-18 4:27 PM View: | Terreri Peter R Director | Impax Laboratories, LLC (IPXL) | 04-May-18 | Disposition | 48,537 | -- | -- | (100%) 48.54K to 0 | |
| 08-May-18 4:24 PM View: | Chao Allen Director | Impax Laboratories, LLC (IPXL) | 04-May-18 | Disposition | 64,037 | -- | -- | (17%) 385.44K to 321.41K | |
| 08-May-18 4:20 PM View: | Benet Leslie Z Director | Impax Laboratories, LLC (IPXL) | 04-May-18 | Disposition | 17,741 | -- | -- | (77%) 23.08K to 5.34K | |
| 08-May-18 4:19 PM View: | Burr Robert L Director | Impax Laboratories, LLC (IPXL) | 04-May-18 | Disposition | 55,067 | -- | -- | (83%) 66.53K to 11.46K | |
| 08-May-18 4:16 PM View: | Schlossberg Mark A SVP and General Counsel | Impax Laboratories, LLC (IPXL) | 04-May-18 | Disposition | 68,251 | -- | -- | (100%) 68.25K to 0 | |
| 08-May-18 4:16 PM View: | Nornhold Jeffrey SVP, Technical Operations | Impax Laboratories, LLC (IPXL) | 04-May-18 | Disposition | 65,878 | -- | -- | (100%) 65.88K to 0 | |
| 08-May-18 4:23 PM View: | Buchi J Kevin Director | Impax Laboratories, LLC (IPXL) | 04-May-18 | Disposition | 11,301 | -- | -- | (100%) 11.3K to 0 | |
| 08-May-18 4:24 PM View: | Chao Allen Director | Impax Laboratories, LLC (IPXL) | 04-May-18 | Disposition | 316,000 | -- | -- | (98%) 321.41K to 5.41K | |
| 08-May-18 4:30 PM View: | Vergis Janet S. Director | Impax Laboratories, LLC (IPXL) | 04-May-18 | Disposition | 12,150 | -- | -- | (100%) 12.15K to 0 | |
| 08-May-18 4:13 PM View: | Boothe Douglas President, Generics Division | Impax Laboratories, LLC (IPXL) | 04-May-18 | Disposition | 55,901 | -- | -- | (100%) 55.9K to 0 | |
| 08-May-18 4:20 PM View: | Benet Leslie Z Director | Impax Laboratories, LLC (IPXL) | 04-May-18 | Disposition | 600 | -- | -- | (11%) 5.34K to 4.74K | |
| 08-May-18 4:19 PM View: | Burr Robert L Director | Impax Laboratories, LLC (IPXL) | 04-May-18 | Disposition | 6,057 | -- | -- | (53%) 11.46K to 5.41K | |
| 08-May-18 4:25 PM View: | Pendergast Mary K Director | Impax Laboratories, LLC (IPXL) | 04-May-18 | Disposition | 22,350 | -- | -- | (100%) 22.35K to 0 | |
| 08-May-18 4:08 PM View: | Reasons Bryan M. Chief Financial Officer | Impax Laboratories, LLC (IPXL) | 04-May-18 | Disposition | 73,989 | -- | -- | (100%) 73.99K to 0 | |
| 05-Mar-18 12:47 PM View: | Schlossberg Mark A SVP and General Counsel | Impax Laboratories, LLC (IPXL) | 02-Mar-18 | Payment of Exercise | 3,273 | $19.50 | $63,823.50 | (4%) 92.52K to 89.25K | 6% |
| 05-Mar-18 12:48 PM View: | Boothe Douglas President, Generics Division | Impax Laboratories, LLC (IPXL) | 02-Mar-18 | Payment of Exercise | 2,041 | $19.50 | $39,799.50 | (3%) 80.59K to 78.55K | 6% |
| 05-Mar-18 12:46 PM View: | Reasons Bryan M. Chief Financial Officer | Impax Laboratories, LLC (IPXL) | 02-Mar-18 | Payment of Exercise | 3,069 | $19.50 | $59,845.50 | (3%) 97.75K to 94.68K | 6% |
| 05-Mar-18 12:49 PM View: | Nornhold Jeffrey SVP, Technical Operations | Impax Laboratories, LLC (IPXL) | 02-Mar-18 | Payment of Exercise | 2,436 | $19.50 | $47,502.00 | (3%) 82.02K to 79.58K | 6% |
| 27-Feb-18 12:19 PM View: | Reasons Bryan M. Chief Financial Officer | Impax Laboratories, LLC (IPXL) | 26-Feb-18 | Payment of Exercise | 6,141 | $20.95 | $128,654.00 | (6%) 103.89K to 97.75K | 13% |
| 27-Feb-18 12:21 PM View: | Nornhold Jeffrey SVP, Technical Operations | Impax Laboratories, LLC (IPXL) | 26-Feb-18 | Payment of Exercise | 4,215 | $20.95 | $88,304.20 | (5%) 86.23K to 82.02K | 13% |
| 27-Feb-18 12:20 PM View: | Nestor Michael President, Impax Specialty | Impax Laboratories, LLC (IPXL) | 26-Feb-18 | Payment of Exercise | 5,547 | $20.95 | $116,210.00 | (5%) 106.94K to 101.4K | 13% |
| 27-Feb-18 12:18 PM View: | Schlossberg Mark A SVP and General Counsel | Impax Laboratories, LLC (IPXL) | 26-Feb-18 | Payment of Exercise | 5,937 | $20.95 | $124,380.00 | (6%) 98.46K to 92.52K | 13% |
| 26-Oct-17 1:08 PM View: | Nornhold Jeffrey SVP, Technical Operations | Impax Laboratories, LLC (IPXL) | 25-Oct-17 | Payment of Exercise | 2,734 | $19.60 | $53,586.40 | (3%) 88.97K to 86.23K | 7% |
| 02-Aug-17 9:15 AM View: | Boothe Douglas President, Generics Division | Impax Laboratories, LLC (IPXL) | 01-Aug-17 | Payment of Exercise | 5,282 | $17.85 | $94,283.70 | (6%) 85.87K to 80.59K | (3%) |
| 01-Jun-17 2:36 PM View: | Nestor Michael President, Impax Specialty | Impax Laboratories, LLC (IPXL) | 31-May-17 | Market Sale | 1,130 | $15.00 | $16,950.00 | (1%) 108.07K to 106.94K | (22%) |
| 17-May-17 3:52 PM View: | Nestor Michael President, Impax Specialty | Impax Laboratories, LLC (IPXL) | 17-May-17 | Market Sale | 857 | $16.48 | $14,119.10 | (< 1%) 108.93K to 108.07K | (11%) |
| 17-May-17 3:48 PM View: | Chao Allen Director | Impax Laboratories, LLC (IPXL) | 16-May-17 | Grant | 4,375 | -- | -- | 1% 381.07K to 385.44K | |
| 17-May-17 3:50 PM View: | Benet Leslie Z Director | Impax Laboratories, LLC (IPXL) | 16-May-17 | Grant | 4,375 | -- | -- | 23% 18.71K to 23.08K | |
| 17-May-17 3:46 PM View: | Burr Robert L Director | Impax Laboratories, LLC (IPXL) | 16-May-17 | Grant | 4,375 | -- | -- | 7% 62.16K to 66.53K | |
| 17-May-17 3:50 PM View: | Buchi J Kevin Director | Impax Laboratories, LLC (IPXL) | 16-May-17 | Grant | 3,281 | -- | -- | 41% 8.02K to 11.3K | |
| 17-May-17 3:46 PM View: | Vergis Janet S. Director | Impax Laboratories, LLC (IPXL) | 16-May-17 | Grant | 4,375 | -- | -- | 56% 7.78K to 12.15K | |
| 17-May-17 3:49 PM View: | Pendergast Mary K Director | Impax Laboratories, LLC (IPXL) | 16-May-17 | Grant | 4,375 | -- | -- | 24% 17.98K to 22.35K | |
| 17-May-17 3:47 PM View: | Bierly Rick Director | Impax Laboratories, LLC (IPXL) | 16-May-17 | Grant | 4,375 | -- | -- | 89% 4.89K to 9.27K | |
| 17-May-17 3:51 PM View: | Terreri Peter R Director | Impax Laboratories, LLC (IPXL) | 16-May-17 | Grant | 4,375 | -- | -- | 10% 44.16K to 48.54K | |
| 16-May-17 2:55 PM View: | Nestor Michael President, Impax Specialty | Impax Laboratories, LLC (IPXL) | 15-May-17 | Payment of Exercise | 3,236 | $16.80 | $54,364.80 | (3%) 112.17K to 108.93K | (9%) |
| 16-May-17 2:56 PM View: | Schlossberg Mark A SVP and General Counsel | Impax Laboratories, LLC (IPXL) | 15-May-17 | Payment of Exercise | 3,488 | $16.80 | $58,598.40 | (3%) 101.94K to 98.46K | (9%) |
| 16-May-17 2:54 PM View: | Reasons Bryan M. Chief Financial Officer | Impax Laboratories, LLC (IPXL) | 15-May-17 | Payment of Exercise | 454 | $16.80 | $7,627.20 | (< 1%) 104.35K to 103.89K | (9%) |
| 16-May-17 2:56 PM View: | Schlossberg Mark A SVP and General Counsel | Impax Laboratories, LLC (IPXL) | 14-May-17 | Payment of Exercise | 3,235 | $17.65 | $57,097.80 | (3%) 105.18K to 101.94K | (4%) |
| 16-May-17 2:54 PM View: | Reasons Bryan M. Chief Financial Officer | Impax Laboratories, LLC (IPXL) | 14-May-17 | Payment of Exercise | 705 | $17.65 | $12,443.20 | (< 1%) 105.05K to 104.35K | (4%) |
| 16-May-17 2:58 PM View: | Nornhold Jeffrey SVP, Technical Operations | Impax Laboratories, LLC (IPXL) | 14-May-17 | Payment of Exercise | 502 | $17.65 | $8,860.30 | (< 1%) 89.47K to 88.97K | (4%) |
| 15-May-17 7:26 PM View: | Nestor Michael President, Impax Specialty | Impax Laboratories, LLC (IPXL) | 14-May-17 | Payment of Exercise | 3,002 | $17.65 | $52,985.30 | (3%) 115.17K to 112.17K | (4%) |
| 15-May-17 7:26 PM View: | Nestor Michael President, Impax Specialty | Impax Laboratories, LLC (IPXL) | 12-May-17 | Market Sale | 700 | $17.11 | $11,977.00 | (< 1%) 115.87K to 115.17K | (7%) |
| 06-Mar-17 3:08 PM View: | Schlossberg Mark A SVP and General Counsel | Impax Laboratories, LLC (IPXL) | 02-Mar-17 | Grant | 23,272 | -- | -- | 28% 81.91K to 105.18K | |
| 06-Mar-17 3:12 PM View: | Nornhold Jeffrey SVP, Technical Operations | Impax Laboratories, LLC (IPXL) | 02-Mar-17 | Grant | 17,317 | -- | -- | 24% 72.15K to 89.47K | |
| 06-Mar-17 3:07 PM View: | Boothe Douglas President, Generics Division | Impax Laboratories, LLC (IPXL) | 02-Mar-17 | Grant | 23,272 | -- | -- | 37% 62.6K to 85.87K | |
| 06-Mar-17 3:08 PM View: | Reasons Bryan M. Chief Financial Officer | Impax Laboratories, LLC (IPXL) | 02-Mar-17 | Grant | 23,272 | -- | -- | 28% 81.78K to 105.05K |
